Grantham, Mayo, Van Otterloo & Co (GMO)
ICL icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s ICL Group ICL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ICL Stock Details ICL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58M Sell
1,312,723
-142,017
-10% -$808K 0.01% 296
2026
Q1 		$7.46M Buy
1,454,740
+661,900
+83% +$3.54M 0.02% 272
2025
Q4 		$4.55M Buy
792,840
+255,334
+48% +$1.48M 0.01% 324
2025
Q3 		$3.37M Buy
537,506
+12,465
+2% +$80.1K 0.01% 327
2025
Q2 		$3.6M Sell
525,041
-86,024
-14% -$562K 0.01% 328
2025
Q1 		$3.43M Sell
611,065
-25,606
-4% -$151K 0.01% 340
2024
Q4 		$3.15M Buy
636,671
+50,127
+9% +$224K 0.01% 340
2024
Q3 		$2.5M Buy
586,544
+504,475
+615% +$2.14M 0.01% 359
2024
Q2 		$355K Buy
+82,069
New +$386K ﹤0.01% 468
2024
Q1 		– Sell
-1,782,282
Closed -$9.06M – 530
2023
Q4 		$9.06M Sell
1,782,282
-4,848,996
-73% -$24.7M 0.04% 246
2023
Q3 		$36.7M Buy
6,631,278
+1,062,203
+19% +$6.41M 0.17% 106
2023
Q2 		$30.2M Buy
5,569,075
+3,350,881
+151% +$20.3M 0.14% 132
2023
Q1 		$14.9M Buy
+2,218,194
New +$16.4M 0.08% 205
2020
Q2 		– Sell
-4,079,716
Closed -$13M – 792
2020
Q1 		$13M Buy
4,079,716
+937,643
+30% +$3.63M 0.11% 124
2019
Q4 		$14.8M Sell
3,142,073
-22,687
-0.7% -$105K 0.1% 147
2019
Q3 		$15.7M Sell
3,164,760
-356,731
-10% -$1.78M 0.11% 132
2019
Q2 		$18.5M Buy
3,521,491
+1,398,864
+66% +$7.41M 0.13% 117
2019
Q1 		$11M Buy
2,122,627
+79,432
+4% +$441K 0.08% 167
2018
Q4 		$11.6M Buy
2,043,195
+221,251
+12% +$1.31M 0.09% 130
2018
Q3 		$11.1M Buy
1,821,944
+45,139
+3% +$239K 0.08% 146
2018
Q2 		$8.11M Buy
1,776,805
+702,847
+65% +$3.22M 0.06% 174
2018
Q1 		$4.53M Buy
1,073,958
+223,152
+26% +$954K 0.03% 238
2017
Q4 		$3.46M Buy
850,806
+242,865
+40% +$1.01M 0.02% 274
2017
Q3 		$2.7M Sell
607,941
-62,399
-9% -$284K 0.02% 300
2017
Q2 		$3.16M Buy
670,340
+166,945
+33% +$719K 0.02% 285
2017
Q1 		$2.13M Sell
503,395
-22,698
-4% -$101K 0.01% 317
2016
Q4 		$2.16M Sell
526,093
-29,178
-5% -$112K 0.01% 311
2016
Q3 		$2.16M Buy
+555,271
New +$2.25M 0.01% 325

Other funds holding ICL

AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ICL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its ICL Group (ICL) stake by 9.8% in Q2 2026, selling an estimated $808K and leaving 1,312,723 shares worth $6.58M. The position accounts for 0.01% of the portfolio, ranked #296.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ICL in Q3 2016 and has held it in 28 quarters since. The position peaked at $36.7M in Q3 2023. 220 funds tracked by Wall St. Rank hold ICL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 1,312,723 shares of ICL Group worth $6.58M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 142,017 ICL Group shares in Q2 2026, an estimated $808K.
  • ICL Group made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #296 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ICL Group in Q3 2016 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ICL Group position peaked at $36.7M in Q3 2023.
  • 220 funds tracked by Wall St. Rank held ICL Group as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.